Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endo Int'l Plc (ENDP)

Endo Int'l Plc (ENDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,248,402
  • Shares Outstanding, K 226,776
  • Annual Sales, $ 2,947 M
  • Annual Income, $ -1,031,470 K
  • 60-Month Beta 1.43
  • Price/Sales 0.38
  • Price/Cash Flow 0.80
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.57
  • Number of Estimates 7
  • High Estimate 0.59
  • Low Estimate 0.55
  • Prior Year 0.75
  • Growth Rate Est. (year over year) -24.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.98 +21.11%
on 11/12/19
5.76 -16.32%
on 12/05/19
+0.38 (+8.44%)
since 11/05/19
3-Month
2.33 +106.87%
on 09/06/19
5.76 -16.32%
on 12/05/19
+2.46 (+104.24%)
since 09/05/19
52-Week
1.97 +144.67%
on 09/05/19
12.49 -61.41%
on 02/28/19
-7.24 (-60.03%)
since 12/04/18

Most Recent Stories

More News
Why Is Endo (ENDP) Up 12.3% Since Last Earnings Report?

Endo (ENDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ENDP : 4.82 (-12.44%)
Options Traders Expect Huge Moves in Endo (ENDP) Stock

Investors need to pay close attention to Endo (ENDP) stock based on the movements in the options market lately.

ENDP : 4.82 (-12.44%)
J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders

J&J (JNJ) says that two third-party labs conducted 155 tests on samples of its baby powders. All these tests confirm that the talc does not contain asbestos, a known carcinogen.

JNJ : 139.56 (+0.13%)
ENDP : 4.82 (-12.44%)
TEVA : 9.82 (-5.03%)
MNK : 3.38 (-12.89%)
BioDelivery's Belbuca Sales & Symproic Addition Encouraging

BioDelivery's (BDSI) efforts to increase preferred coverage for Belbuca and the acquisition of the rights to Symproic are likely to help continue its momentum.

CI : 195.59 (-0.58%)
BDSI : 6.49 (-3.13%)
ALKS : 20.65 (-2.73%)
ENDP : 4.82 (-12.44%)
Fed Reportedly Opens Criminal Investigation on Opioid Makers

Shares of some manufacturers and distributors of opioid drugs decline on Tuesday following reports that a criminal probe has been initiated by federal prosecutors.

JNJ : 139.56 (+0.13%)
ENDP : 4.82 (-12.44%)
MNK : 3.38 (-12.89%)
TEVA : 9.82 (-5.03%)
MCK : 140.61 (-1.64%)
ABC : 87.82 (-0.61%)
AMRX : 3.71 (-8.40%)
Specialty Generic Drugs Market 2018-2025|Market Size, Market Status, Top key players, and Forecasts

The global Specialty Generic Drugs Market is anticipated to reach USD 190.9 billion by 2025 according to a new study published by Polaris Market Research. Specialty Generics drugs are the generic forms...

ENDP : 4.82 (-12.44%)
NVS : 91.64 (+0.09%)
PFE : 38.03 (-0.29%)
VRX.TO : 30.80 (-3.33%)
Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton, Florida...

ENDP : 4.82 (-12.44%)
Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA

The FDA accepts Endo's (ENDP) BLA for CCH for the treatment of cellulite in the buttocks.

ENDP : 4.82 (-12.44%)
JAZZ : 148.10 (-0.04%)
MNK : 3.38 (-12.89%)
TEVA : 9.82 (-5.03%)
Company News For Nov 21, 2019

Companies in the news are: URBN, KNSA, ACB, ENDP

ENDP : 4.82 (-12.44%)
URBN : 25.37 (+0.75%)
KNSA : 9.97 (-0.80%)
ACB : 2.44 (-1.61%)
Why the Global Pain Management Drug Market is Adopting More Non-Opioid Options

It appears that the reign of the opioid drugs in the global pain management markets could be coming to an end. While opioids have long been the 'best' choice to address the pain patients suffer from various...

QBIO : 1.5000 (+1.35%)
MYOV : 16.78 (-3.12%)
HRTX : 25.64 (-3.06%)
BCRX : 2.60 (-7.80%)
ENDP : 4.82 (-12.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade ENDP with:

Business Summary

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova,...

See More

Key Turning Points

2nd Resistance Point 6.09
1st Resistance Point 5.46
Last Price 4.82
1st Support Level 4.49
2nd Support Level 4.15

See More

52-Week High 12.49
Fibonacci 61.8% 8.47
Fibonacci 50% 7.23
Fibonacci 38.2% 5.99
Last Price 4.82
52-Week Low 1.97

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar